ロード中...
HIV-1 IN Inhibitors: 2010 Update and Perspectives
Integrase (IN) is the newest validated target against AIDS and retroviral infections. The remarkable activity of raltegravir (Isentress(®)) led to its rapid approval by the FDA in 2007 as the first IN inhibitor. Several other IN strand transfer inhibitors (STIs) are in development with the primary g...
保存先:
| 主要な著者: | , , , |
|---|---|
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2009
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC2860603/ https://ncbi.nlm.nih.gov/pubmed/19747122 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|